Table 1:
Age-standardised incidence of major cancers in people living with HIV in Australia between 1982 – 2012 (per 100,000 person-years) in three age groups, and overall.
Cancer1 | Age Group | 1982-1995 | 1996-1999 | 2000-2004 | 2005-2008 | 2009-2012 | p-value* |
---|---|---|---|---|---|---|---|
AID defining cancers | |||||||
| |||||||
Kaposi sarcoma | Overall | 996.70 | 305.20 | 123.85 | 63.04 | 64.79 | <0.001 |
15-34 | 791.77 | 295.36 | 98.84 | 36.59 | 48.73 | <0.001 | |
35-64 | 1220.95 | 323.92 | 109.62 | 86.93 | 71.16 | <0.001 | |
65- | 144.70 | 0.00 | 35.54 | 0.00 | 19.87 | 0.995 | |
| |||||||
Non-Hodgkin lymphoma | Overall | 658.62 | 343.04 | 121.68 | 112.89 | 71.08 | <0.001 |
15-34 | 292.37 | 346.37 | 73.87 | 117.16 | 45.89 | 0.027 | |
35-64 | 770.93 | 362.86 | 152.35 | 101.65 | 91.62 | <0.001 | |
65- | 901.74 | 133.84 | 52.38 | 101.92 | 82.29 | 0.001 | |
| |||||||
Infection related non-AID defining cancers | |||||||
| |||||||
Anal cancer | Overall | 26.82 | 18.76 | 25.40 | 38.41 | 44.97 | 0.002 |
15-34 | 4.41 | 12.40 | 0.00 | 4.55 | 4.34 | 0.621 | |
35-64 | 24.49 | 16.99 | 41.13 | 41.69 | 66.44 | <0.001 | |
65- | 84.83 | 0.00 | 34.86 | 105.22 | 71.43 | 0.553 | |
| |||||||
Hodgkin lymphoma | Overall | 13.63 | 26.58 | 16.14 | 29.23 | 23.39 | 0.314 |
15-34 | 10.48 | 18.20 | 5.90 | 9.11 | 4.35 | 0.222 | |
35-64 | 14.19 | 20.40 | 17.70 | 32.04 | 37.25 | <0.001 | |
65- | 0.00 | 45.27 | 34.62 | 41.38 | 24.14 | 0.550 | |
| |||||||
Liver cancer | Overall | 2.00 | 4.04 | 9.06 | 8.96 | 14.79 | <0.001 |
15-34 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | N/A | |
35-64 | 4.13 | 8.35 | 13.32 | 18.53 | 26.65 | <0.001 | |
65- | 0.00 | 0.00 | 16.57 | 0.00 | 12.03 | 0.470 | |
| |||||||
Head and neck cancer | Overall | 10.67 | 2.87 | 9.61 | 5.77 | 7.64 | 0.765 |
15-34 | 0.00 | 2.99 | 0.00 | 0.00 | 0.00 | N/A | |
35-64 | 22.05 | 3.72 | 14.43 | 11.93 | 15.79 | 0.839 | |
65- | 0.00 | 0.00 | 16.67 | 0.00 | 0.00 | N/A | |
| |||||||
Non-infection related non-AID defining cancers | |||||||
| |||||||
Lip cancer | Overall | 12.10 | 18.23 | 7.10 | 3.86 | 7.56 | 0.147 |
15-34 | 1.88 | 0.00 | 0.00 | 4.55 | 0.00 | 0.917 | |
35-64 | 22.07 | 22.86 | 14.68 | 4.60 | 9.58 | 0.006 | |
65- | 0.00 | 45.42 | 0.00 | 0.00 | 18.55 | 0.912 | |
| |||||||
Lung cancer | Overall | 13.85 | 26.48 | 27.47 | 16.72 | 31.17 | 0.300 |
15-34 | 4.41 | 0.00 | 0.00 | 0.00 | 0.00 | N/A | |
35-64 | 9.88 | 39.82 | 29.04 | 27.09 | 39.96 | 0.227 | |
65- | 47.42 | 45.71 | 85.02 | 22.89 | 75.01 | 0.716 | |
| |||||||
Colorectal cancer | Overall | 11.51 | 8.98 | 5.99 | 7.73 | 22.63 | 0.238 |
15-34 | 0.00 | 0.00 | 0.00 | 0.00 | 7.47 | N/A | |
35-64 | 8.27 | 3.72 | 12.38 | 12.22 | 19.97 | 0.003 | |
65- | 47.58 | 45.49 | 0.00 | 11.50 | 44.59 | 0525 | |
| |||||||
Stomach cancer | Overall | 7.44 | 0.00 | 7.47 | 8.34 | 5.81 | 0.665 |
15-34 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | N/A | |
35-64 | 0.00 | 0.00 | 10.03 | 0.00 | 9.91 | 0.382 | |
65- | 47.10 | 0.00 | 16.58 | 52.81 | 6.45 | 0.736 | |
| |||||||
Melanoma | Overall | 39.61 | 31.98 | 28.02 | 30.67 | 33.00 | 0.249 |
15-34 | 14.59 | 15.40 | 23.43 | 0.00 | 4.35 | 0.291 | |
35-64 | 57.25 | 42.09 | 21.48 | 32.09 | 37.33 | 0.142 | |
65- | 47.42 | 0.00 | 16.72 | 95.97 | 84.77 | 0.132 | |
| |||||||
Prostate cancer | Overall | 49.72 | 35.47 | 24.28 | 66.39 | 39.44 | 0.853 |
15-34 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | N/A | |
35-64 | 59.00 | 16.43 | 5.48 | 44.66 | 50.17 | 0.869 | |
65- | 134.18 | 174.35 | 137.00 | 283.65 | 96.13 | 0.906 |
Linear regression model p value for trend
ICD10/O-3 codes: Kaposi sarcoma 9140, 8000 if KS on AIDS Registry, non-Hodgkin lymphoma 9591 9596, 9670-9729, 9820-9837, 9940, 9948 and 9590 if ICD10 C82-C85; Diffuse large B cell lymphoma 9680, 9684, 9678, 9679; Burkitt 9687, 9826; CNS lymphoma, non-Hodgkin lymphoma with C70-C72 topography; Hodgkin lymphoma 9650-9667; anus C21; Head and Neck cancer C01-C10, excluding C07-C08; liver C22; lip C00; melanoma c43; trachea, bronchus and lung C33-C34; colorectal C18-C20; prostate C61